Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jumptuit is a private artificial intelligence and software company focused on scenario forecasting and what it calls "Anticipatory Intelligence." The company develops AI systems, including Genesis J2T and Event Genesis Intelligence, to analyze cross-sector, real-time data and forecast risks, opportunities, and future events for enterprises, governments, and other organizations. Its business spans multiple industry verticals, including finance, insurance, transport and logistics, energy, critical minerals, health, and travel, but it does not appear to be a biotech, pharma, or healthcare therapeutics company. Jumptuit operates as The Jumptuit Group, an interconnected network of sector-specific subsidiaries that share a common technology, licensing, and business model framework. The company is private, active, and appears to commercialize AI software and intellectual property rather than drug development assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jumptuit.